MetLife Investment Management’s Cerus CERS Stock Holding History

MetLife Investment Management’s Portfolio CERS Stock Details CERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$116K	Sell	63,517 -28,101	-31%	-$61.2K	﹤0.01%	2475
2025 Q4	$189K	Buy	91,618 +8,438	+10%	+$14.6K	﹤0.01%	2302
2025 Q3	$132K	Sell	83,180 -27,585	-25%	-$37.3K	﹤0.01%	2524
2025 Q2	$156K	Buy	110,765 +492	+0.4%	+$656	﹤0.01%	2309
2025 Q1	$153K	Buy	110,273 +58,123	+111%	+$97.3K	﹤0.01%	2327
2024 Q4	$80.3K	Sell	52,150 -50,585	-49%	-$87K	﹤0.01%	2690
2024 Q3	$179K	Hold	102,735	–	–	﹤0.01%	2340
2024 Q2	$181K	Buy	102,735 +11,820	+13%	+$21.1K	﹤0.01%	2317
2024 Q1	$172K	Sell	90,915 -334	-0.4%	-$681	﹤0.01%	2275
2023 Q4	$197K	Hold	91,249	–	–	﹤0.01%	2257
2023 Q3	$148K	Hold	91,249	–	–	﹤0.01%	2371
2023 Q2	$224K	Hold	91,249	–	–	﹤0.01%	2198
2023 Q1	$271K	Buy	91,249 +8,272	+10%	+$24.9K	﹤0.01%	2038
2022 Q4	$303K	Sell	82,977 -9,443	-10%	-$35.6K	﹤0.01%	1987
2022 Q3	$333K	Buy	92,420 +16,869	+22%	+$80.7K	﹤0.01%	1922
2022 Q2	$400K	Sell	75,551 -17,437	-19%	-$87.1K	﹤0.01%	1819
2022 Q1	$511K	Buy	92,988 +33,174	+55%	+$184K	﹤0.01%	1765
2021 Q4	$407K	Buy	59,814 +8,229	+16%	+$55.4K	﹤0.01%	1617
2021 Q3	$314K	Sell	51,585 -13,139	-20%	-$76.6K	﹤0.01%	1798
2021 Q2	$383K	Hold	64,724	–	–	﹤0.01%	1736
2021 Q1	$389K	Sell	64,724 -3,741	-5%	-$25.5K	﹤0.01%	1665
2020 Q4	$474K	Sell	68,465 -2,192	-3%	-$14.4K	﹤0.01%	1518
2020 Q3	$442K	Hold	70,657	–	–	﹤0.01%	1429
2020 Q2	$466K	Hold	70,657	–	–	0.01%	1417
2020 Q1	$329K	Buy	70,657 +12,331	+21%	+$55.8K	﹤0.01%	1444
2019 Q4	$246K	Hold	58,326	–	–	﹤0.01%	1865
2019 Q3	$301K	Hold	58,326	–	–	﹤0.01%	1705
2019 Q2	$328K	Hold	58,326	–	–	﹤0.01%	1741
2019 Q1	$363K	Hold	58,326	–	–	﹤0.01%	1641
2018 Q4	$296K	Hold	58,326	–	–	﹤0.01%	1686
2018 Q3	$421K	Hold	58,326	–	–	﹤0.01%	1641
2018 Q2	$389K	Hold	58,326	–	–	﹤0.01%	1562
2018 Q1	$320K	Hold	58,326	–	–	﹤0.01%	1641
2017 Q4	$197K	Buy	+58,326	New	+$197K	﹤0.01%	1936

Other funds holding CERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

MetLife Investment Management's CERS Position: Q1 2026 in Review

MetLife Investment Management reduced its Cerus (CERS) stake by 31% in Q1 2026, selling an estimated $61.2K and leaving 63,517 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

MetLife Investment Management first reported a position in CERS in Q4 2017 and has held it in 34 quarters since. The position peaked at $511K in Q1 2022. 168 funds tracked by Wall St. Rank hold CERS as of Q1 2026.

MetLife Investment Management held 63,517 shares of Cerus worth $116K as of Q1 2026.
MetLife Investment Management sold 28,101 Cerus shares in Q1 2026, an estimated $61.2K.
Cerus made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2475 holding.
MetLife Investment Management first reported a position in Cerus in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's Cerus position peaked at $511K in Q1 2022.
168 funds tracked by Wall St. Rank held Cerus as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.